{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:35:34Z","timestamp":1791945334066,"version":"4.3.4"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>VP30 and VP40 proteins of Ebola and Marburg viruses have been recognized as potential targets for antiviral drug development due to their essential roles in the viral lifecycle. Targeting these proteins could disrupt key stages of the viral replication process, inhibiting the viruses\u2019 ability to propagate and cause disease. The current study aims to perform molecular docking and virtual screening on deep-sea fungal metabolites targeting Marburg virus VP40 Dimer, matrix protein VP40 from Ebola virus Sudan, Ebola VP35 Interferon Inhibitory Domain, and VP35 from Marburg virus. The top ten compounds for each protein target were chosen using the glide score. All the compounds obtained indicate a positive binding interaction. Furthermore, AdmetSAR was utilized to investigate the pharmacokinetics of the inhibitors chosen. Gliotoxin was used as a ligand with Marburg virus VP40 Dimer, Austinol with matrix protein VP40 from Ebola virus Sudan, Ozazino-cyclo-(2,3-dihydroxyl-trp-tyr) with Ebola VP35 Interferon Inhibitory Domain, and Dehydroaustinol with VP35 from Marburg virus. MD modeling and MMPBSA studies were used to provide a better understanding of binding behaviors. Pre-clinical experiments can assist validate our <jats:italic>in-silico<\/jats:italic> studies and assess whether the molecule can be employed as an anti-viral drug.<\/jats:p>","DOI":"10.1371\/journal.pone.0307579","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T17:29:43Z","timestamp":1721928583000},"page":"e0307579","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["In silico exploration of deep-sea fungal metabolites as inhibitor of Ebola and Marburg VP35 and VP40"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2565-6573","authenticated-orcid":true,"given":"Abdullah R.","family":"Alanzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed F.","family":"Alajmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Al-Dosari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad K.","family":"Parvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moneerah J.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"issue":"3","key":"pone.0307579.ref001","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0168-1702(93)90063-S","article-title":"Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus","volume":"29","author":"A Sanchez","year":"1993","journal-title":"Virus research"},{"issue":"5","key":"pone.0307579.ref002","doi-asserted-by":"crossref","first-page":"e02243","DOI":"10.1128\/mbio.02243-22","article-title":"Marburg Virus VP30 Is Required for Transcription Initiation at the Glycoprotein Gene.","volume":"13","author":"MR Edwards","year":"2022","journal-title":"Mbio"},{"issue":"24","key":"pone.0307579.ref003","doi-asserted-by":"crossref","first-page":"12569","DOI":"10.1128\/JVI.01395-08","article-title":"Role of Ebola virus VP30 in transcription reinitiation","volume":"82","author":"MJ Martinez","year":"2008","journal-title":"Journal of virology"},{"issue":"2","key":"pone.0307579.ref004","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1128\/JVI.80.2.1038-1043.2006","article-title":"Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30","volume":"80","author":"S Enterlein","year":"2006","journal-title":"Journal of virology"},{"issue":"25","key":"pone.0307579.ref005","doi-asserted-by":"crossref","first-page":"13871","DOI":"10.1073\/pnas.250277297","article-title":"A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding","volume":"97","author":"RN Harty","year":"2000","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"pone.0307579.ref006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.2001.0860","article-title":"Vesicular release of Ebola virus matrix protein VP40","volume":"283","author":"J Timmins","year":"2001","journal-title":"Virology"},{"issue":"10","key":"pone.0307579.ref007","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1128\/JVI.76.10.4855-4865.2002","article-title":"Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP","volume":"76","author":"T Noda","year":"2002","journal-title":"Journal of virology"},{"issue":"2","key":"pone.0307579.ref008","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1517\/14728222.2014.863877","article-title":"Could the Ebola virus matrix protein VP40 be a drug target?","volume":"18","author":"RV Stahelin","year":"2014","journal-title":"Expert opinion on therapeutic targets."},{"key":"pone.0307579.ref009","doi-asserted-by":"crossref","first-page":"832957","DOI":"10.3389\/fmars.2022.832957","article-title":"Novel bioactive compounds from marine sources as a tool for functional food development","volume":"9","author":"S Ghosh","year":"2022","journal-title":"Frontiers in Marine Science"},{"issue":"2","key":"pone.0307579.ref010","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1021\/np030372w","article-title":"Biologically active compounds from Aphyllophorales (polypore) fungi.","volume":"67","author":"JK Zjawiony","year":"2004","journal-title":"Journal of natural products"},{"issue":"8","key":"pone.0307579.ref011","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.3390\/md13084594","article-title":"A brief review of bioactive metabolites derived from deep-sea fungi.","volume":"13","author":"Y-T Wang","year":"2015","journal-title":"Marine drugs."},{"issue":"1","key":"pone.0307579.ref012","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/md18010009","article-title":"Deep-sea fungi could be the new arsenal for bioactive molecules.","volume":"18","author":"M Zain ul Arifeen","year":"2019","journal-title":"Marine drugs."},{"issue":"D1","key":"pone.0307579.ref013","doi-asserted-by":"crossref","first-page":"D437","DOI":"10.1093\/nar\/gkaa1038","article-title":"RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences","volume":"49","author":"SK Burley","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"pone.0307579.ref014","author":"B Webb","year":"2021","journal-title":"Protein structure modeling with MODELLER: Springer"},{"issue":"1","key":"pone.0307579.ref015","first-page":"82","article-title":"Pymol: An open-source molecular graphics tool.","volume":"40","author":"WL DeLano","year":"2002","journal-title":"CCP4 Newsl Protein Crystallogr"},{"issue":"D1","key":"pone.0307579.ref016","doi-asserted-by":"crossref","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","article-title":"PubChem 2019 update: improved access to chemical data","volume":"47","author":"S Kim","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"pone.0307579.ref017","first-page":"111","author":"Q Li","year":"2017","journal-title":"Structure-based virtual screening"},{"issue":"1","key":"pone.0307579.ref018","first-page":"9.12. 1","volume":"49","author":"MPJCpip Pollastri","year":"2010","journal-title":"Overview on the Rule of Five"},{"issue":"16","key":"pone.0307579.ref019","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"D Van Der Spoel","year":"2005","journal-title":"Journal of computational chemistry"},{"issue":"1","key":"pone.0307579.ref020","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41401-019-0228-6","article-title":"CB-Dock: A web server for cavity detection-guided protein\u2013ligand blind docking.","volume":"41","author":"Y Liu","year":"2020","journal-title":"%J Acta Pharmacologica Sinica."},{"issue":"3","key":"pone.0307579.ref021","first-page":"175a","article-title":"CHARMM36: An improved force field for folded and intrinsically disordered proteins.","volume":"112","author":"J Huang","year":"2017"},{"issue":"7","key":"pone.0307579.ref022","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.cclet.2020.03.028","article-title":"New techniques and strategies in drug discovery","volume":"31","author":"J Du","year":"2020","journal-title":"Chinese Chemical Letters"},{"key":"pone.0307579.ref023","first-page":"107686","article-title":"The strategies and techniques of drug discovery from natural products. Pharmacology &","volume":"216","author":"L Zhang","year":"2020","journal-title":"Therapeutics"},{"key":"pone.0307579.ref024","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fchem.2020.00343","article-title":"Structure-based virtual screening: from classical to artificial intelligence.","volume":"8","author":"EHB Maia","year":"2020","journal-title":"Frontiers in chemistry"},{"key":"pone.0307579.ref025","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/bs.pmch.2021.01.004","article-title":"Use of molecular docking computational tools in drug discovery","volume":"60","author":"F Stanzione","year":"2021","journal-title":"Progress in Medicinal Chemistry"},{"issue":"4","key":"pone.0307579.ref026","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2174\/1570163817666200806165934","article-title":"Insights into Machine Learning-based approaches for Virtual Screening in Drug Discovery: Existing strategies and streamlining through FP-CADD.","volume":"18","author":"W Hussain","year":"2021","journal-title":"Current Drug Discovery Technologies."},{"key":"pone.0307579.ref027","doi-asserted-by":"crossref","first-page":"1060076","DOI":"10.3389\/fmolb.2023.1060076","article-title":"Identification of novel inhibitors for SARS-CoV-2 as therapeutic options using machine learning-based virtual screening, molecular docking and MD simulation.","volume":"10","author":"A Samad","year":"2023","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"17","key":"pone.0307579.ref028","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1080\/07391102.2019.1695670","article-title":"Virtual screening to identify novel potential inhibitors for Glutamine synthetase of Mycobacterium tuberculosis","volume":"38","author":"M Kumari","year":"2020","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"issue":"15","key":"pone.0307579.ref029","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.3390\/ijms23158635","article-title":"Identification of Novel Inhibitors Targeting SGK1 via Ensemble-Based Virtual Screening Method, Biological Evaluation and Molecular Dynamics Simulation.","volume":"23","author":"H Zhang","year":"2022","journal-title":"International Journal of Molecular Sciences."},{"key":"pone.0307579.ref030","doi-asserted-by":"crossref","first-page":"100583","DOI":"10.1016\/j.imu.2021.100583","article-title":"Identification of novel anti-cryptosporidial inhibitors through a combined approach of pharmacophore modeling, virtual screening, and molecular docking.","volume":"24","author":"K Katiyar","year":"2021","journal-title":"Informatics in Medicine Unlocked"},{"issue":"6","key":"pone.0307579.ref031","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3390\/biom14060660","article-title":"Identification of Prospective Ebola Virus VP35 and VP40 Protein Inhibitors from Myxobacterial Natural Products.","volume":"14","author":"M Hayat","year":"2024","journal-title":"Biomolecules"},{"issue":"7","key":"pone.0307579.ref032","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.3390\/ijms24076298","article-title":"Cheminformatics-based study identifies potential Ebola VP40 inhibitors.","volume":"24","author":"E Broni","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"pone.0307579.ref033","first-page":"1","article-title":"Identification of novel inhibitors against VP40 protein of Marburg virus by integrating molecular modeling and dynamics approaches","author":"M Saeed","year":"2023","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"key":"pone.0307579.ref034","first-page":"1","article-title":"ADME profiling in drug discovery and a new path paved on silica.","author":"A Kr\u00fcger","year":"2019","journal-title":"Drug discovery and development-new advances."},{"issue":"7451","key":"pone.0307579.ref035","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nature12205","article-title":"Small molecule inhibition of the KRAS\u2013PDE\u03b4 interaction impairs oncogenic KRAS signalling","volume":"497","author":"G Zimmermann","year":"2013","journal-title":"Nature"},{"issue":"6","key":"pone.0307579.ref036","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.bpj.2015.08.001","article-title":"Molecular simulations of solved co-crystallized X-ray structures identify action mechanisms of PDE\u03b4 inhibitors","volume":"109","author":"RE Salmas","year":"2015","journal-title":"Biophysical journal"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0307579","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T17:30:13Z","timestamp":1721928613000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0307579"}},"subtitle":[],"editor":[{"given":"Sheikh Arslan","family":"Sehgal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0307579","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,25]]}}}